

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cholesterol esterification (GO:0010872) | 7.55844635 |
| 2 | high-density lipoprotein particle remodeling (GO:0034375) | 7.44054597 |
| 3 | plasma lipoprotein particle assembly (GO:0034377) | 7.20469706 |
| 4 | phospholipid efflux (GO:0033700) | 7.12326152 |
| 5 | reverse cholesterol transport (GO:0043691) | 6.54112628 |
| 6 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.48499131 |
| 7 | plasma lipoprotein particle remodeling (GO:0034369) | 6.16590856 |
| 8 | protein-lipid complex remodeling (GO:0034368) | 6.16590856 |
| 9 | macromolecular complex remodeling (GO:0034367) | 6.16590856 |
| 10 | protein-lipid complex assembly (GO:0065005) | 6.15754510 |
| 11 | regulation of triglyceride catabolic process (GO:0010896) | 6.15334754 |
| 12 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.04884310 |
| 13 | negative regulation of fibrinolysis (GO:0051918) | 5.85819495 |
| 14 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 5.84478000 |
| 15 | regulation of protein activation cascade (GO:2000257) | 5.83854630 |
| 16 | negative regulation of lipase activity (GO:0060192) | 5.83535191 |
| 17 | complement activation, alternative pathway (GO:0006957) | 5.68042812 |
| 18 | cholesterol efflux (GO:0033344) | 5.63226561 |
| 19 | phospholipid homeostasis (GO:0055091) | 5.40117150 |
| 20 | regulation of fibrinolysis (GO:0051917) | 5.32735665 |
| 21 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.30488481 |
| 22 | L-phenylalanine catabolic process (GO:0006559) | 5.30488481 |
| 23 | plasma lipoprotein particle organization (GO:0071827) | 5.30310646 |
| 24 | regulation of complement activation (GO:0030449) | 5.22706293 |
| 25 | plasma lipoprotein particle clearance (GO:0034381) | 5.09272301 |
| 26 | low-density lipoprotein particle remodeling (GO:0034374) | 4.92112254 |
| 27 | protein carboxylation (GO:0018214) | 4.88900331 |
| 28 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.88900331 |
| 29 | negative regulation of sterol transport (GO:0032372) | 4.85838245 |
| 30 | negative regulation of cholesterol transport (GO:0032375) | 4.85838245 |
| 31 | protein-lipid complex subunit organization (GO:0071825) | 4.84718058 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.58216090 |
| 33 | L-phenylalanine metabolic process (GO:0006558) | 4.58216090 |
| 34 | negative regulation of glycogen biosynthetic process (GO:0045719) | 4.41642448 |
| 35 | blood coagulation, intrinsic pathway (GO:0007597) | 4.36585706 |
| 36 | glyoxylate metabolic process (GO:0046487) | 4.35018154 |
| 37 | regulation of lipoprotein particle clearance (GO:0010984) | 4.34802735 |
| 38 | triglyceride homeostasis (GO:0070328) | 4.29545370 |
| 39 | acylglycerol homeostasis (GO:0055090) | 4.29545370 |
| 40 | cellular glucuronidation (GO:0052695) | 4.01278738 |
| 41 | bile acid biosynthetic process (GO:0006699) | 3.99717629 |
| 42 | aromatic amino acid family catabolic process (GO:0009074) | 3.98310281 |
| 43 | regulation of lipoprotein metabolic process (GO:0050746) | 3.89777562 |
| 44 | glucuronate metabolic process (GO:0019585) | 3.89580914 |
| 45 | uronic acid metabolic process (GO:0006063) | 3.89580914 |
| 46 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 3.89556391 |
| 47 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.88745207 |
| 48 | positive regulation of lipid catabolic process (GO:0050996) | 3.88507791 |
| 49 | intestinal cholesterol absorption (GO:0030299) | 3.78354579 |
| 50 | negative regulation of protein activation cascade (GO:2000258) | 3.78214835 |
| 51 | cholesterol homeostasis (GO:0042632) | 3.65990500 |
| 52 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62810531 |
| 53 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62810531 |
| 54 | heme transport (GO:0015886) | 3.58922539 |
| 55 | cholesterol transport (GO:0030301) | 3.57919191 |
| 56 | sterol transport (GO:0015918) | 3.57919191 |
| 57 | sterol homeostasis (GO:0055092) | 3.57089566 |
| 58 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.53103775 |
| 59 | fibrinolysis (GO:0042730) | 3.49575792 |
| 60 | negative regulation of blood coagulation (GO:0030195) | 3.42103970 |
| 61 | negative regulation of hemostasis (GO:1900047) | 3.42103970 |
| 62 | lipoprotein metabolic process (GO:0042157) | 3.39514059 |
| 63 | serine family amino acid catabolic process (GO:0009071) | 3.35028909 |
| 64 | drug catabolic process (GO:0042737) | 3.33498749 |
| 65 | response to dietary excess (GO:0002021) | 3.33312728 |
| 66 | bile acid metabolic process (GO:0008206) | 3.32927693 |
| 67 | protein activation cascade (GO:0072376) | 3.30589095 |
| 68 | regulation of humoral immune response (GO:0002920) | 3.28640396 |
| 69 | negative regulation of glycogen metabolic process (GO:0070874) | 3.28125822 |
| 70 | hormone catabolic process (GO:0042447) | 3.27712559 |
| 71 | flavonoid metabolic process (GO:0009812) | 3.25512704 |
| 72 | urea metabolic process (GO:0019627) | 3.25355309 |
| 73 | epoxygenase P450 pathway (GO:0019373) | 3.19458176 |
| 74 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.15541039 |
| 75 | cellular anion homeostasis (GO:0030002) | 3.14128143 |
| 76 | lipoprotein transport (GO:0042953) | 3.13949917 |
| 77 | acute-phase response (GO:0006953) | 3.13654852 |
| 78 | tyrosine metabolic process (GO:0006570) | 3.12491881 |
| 79 | regulation of sterol transport (GO:0032371) | 3.09507488 |
| 80 | regulation of cholesterol transport (GO:0032374) | 3.09507488 |
| 81 | negative regulation of coagulation (GO:0050819) | 3.09312334 |
| 82 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.07525389 |
| 83 | drug metabolic process (GO:0017144) | 3.07213482 |
| 84 | regulation of plasminogen activation (GO:0010755) | 3.02552243 |
| 85 | lipid homeostasis (GO:0055088) | 3.01672267 |
| 86 | imidazole-containing compound metabolic process (GO:0052803) | 3.01049446 |
| 87 | positive regulation of steroid metabolic process (GO:0045940) | 2.99685496 |
| 88 | bile acid and bile salt transport (GO:0015721) | 2.98409467 |
| 89 | negative regulation of wound healing (GO:0061045) | 2.98045404 |
| 90 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.96734319 |
| 91 | ethanol oxidation (GO:0006069) | 2.96613114 |
| 92 | xenobiotic catabolic process (GO:0042178) | 2.96345957 |
| 93 | positive regulation of hemostasis (GO:1900048) | 2.92320797 |
| 94 | positive regulation of blood coagulation (GO:0030194) | 2.92320797 |
| 95 | urea cycle (GO:0000050) | 2.89907282 |
| 96 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.85679530 |
| 97 | anion homeostasis (GO:0055081) | 2.83856673 |
| 98 | nitrogen cycle metabolic process (GO:0071941) | 2.83438738 |
| 99 | diacylglycerol metabolic process (GO:0046339) | 2.83362002 |
| 100 | indolalkylamine catabolic process (GO:0046218) | 2.80818548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.58605494 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.71929838 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.25325683 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.12201374 |
| 5 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.08972280 |
| 6 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.47257175 |
| 7 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.30860345 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.26760143 |
| 9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.83459378 |
| 10 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.58671753 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.42060681 |
| 12 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.23647916 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.11802820 |
| 14 | IRF1_19129219_ChIP-ChIP_H3396_Human | 2.01840621 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.91850797 |
| 16 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.71555886 |
| 17 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.66649444 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.65676391 |
| 19 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.54312328 |
| 20 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.43736013 |
| 21 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.39495213 |
| 22 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 1.38012847 |
| 23 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.36125851 |
| 24 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.28235075 |
| 25 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.27581507 |
| 26 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24514738 |
| 27 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24514738 |
| 28 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.23095149 |
| 29 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.21953594 |
| 30 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.20787223 |
| 31 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.20019294 |
| 32 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.12777001 |
| 33 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11773767 |
| 34 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.11159561 |
| 35 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07744026 |
| 36 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.03595799 |
| 37 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.00516665 |
| 38 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.99188785 |
| 39 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.99188785 |
| 40 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99188126 |
| 41 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.98909238 |
| 42 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98891478 |
| 43 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.98000159 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.97514698 |
| 45 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.96549465 |
| 46 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96401840 |
| 47 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.95117361 |
| 48 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.94984564 |
| 49 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 0.94854965 |
| 50 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91712434 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89259841 |
| 52 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.88336320 |
| 53 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86138358 |
| 54 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.85819518 |
| 55 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.85447326 |
| 56 | ERA_21632823_ChIP-Seq_H3396_Human | 0.85349001 |
| 57 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.85249674 |
| 58 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.85249674 |
| 59 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.84924472 |
| 60 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.84678909 |
| 61 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.84333344 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.84230881 |
| 63 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.83368064 |
| 64 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.82495662 |
| 65 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.82464464 |
| 66 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.81864781 |
| 67 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.81308868 |
| 68 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.80944821 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.80648618 |
| 70 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.77735657 |
| 71 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.77697342 |
| 72 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.77584308 |
| 73 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.77002001 |
| 74 | TCF4_23295773_ChIP-Seq_U87_Human | 0.76877131 |
| 75 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 0.76640700 |
| 76 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.76524665 |
| 77 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 0.76135563 |
| 78 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.75052483 |
| 79 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75024521 |
| 80 | NCOR_22424771_ChIP-Seq_293T_Human | 0.72852494 |
| 81 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.72474682 |
| 82 | STAT3_23295773_ChIP-Seq_U87_Human | 0.72417028 |
| 83 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.71695595 |
| 84 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.70516824 |
| 85 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.70310089 |
| 86 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.70115243 |
| 87 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.69759082 |
| 88 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.69614007 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.69283267 |
| 90 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.69113657 |
| 91 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.69113657 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.69007880 |
| 93 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.68777953 |
| 94 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.68774823 |
| 95 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.68225737 |
| 96 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.68116617 |
| 97 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.67840332 |
| 98 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.67671479 |
| 99 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.67570335 |
| 100 | AR_20517297_ChIP-Seq_VCAP_Human | 0.67278142 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.41373284 |
| 2 | MP0009840_abnormal_foam_cell | 4.33241988 |
| 3 | MP0005360_urolithiasis | 4.28221313 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 4.23958689 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.94492295 |
| 6 | MP0010329_abnormal_lipoprotein_level | 3.52492049 |
| 7 | MP0005365_abnormal_bile_salt | 3.32398339 |
| 8 | MP0003195_calcinosis | 2.72190848 |
| 9 | MP0001666_abnormal_nutrient_absorption | 2.71355300 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.52515946 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.52198145 |
| 12 | MP0003122_maternal_imprinting | 2.45841174 |
| 13 | MP0002876_abnormal_thyroid_physiology | 2.39984971 |
| 14 | MP0003252_abnormal_bile_duct | 2.38127625 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.26355302 |
| 16 | MP0005408_hypopigmentation | 2.22827411 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.08607458 |
| 18 | MP0000604_amyloidosis | 2.05338985 |
| 19 | MP0003567_abnormal_fetal_cardiomyocyte | 2.04187315 |
| 20 | MP0003868_abnormal_feces_composition | 1.99348402 |
| 21 | MP0009379_abnormal_foot_pigmentation | 1.99030380 |
| 22 | MP0004142_abnormal_muscle_tone | 1.95072026 |
| 23 | MP0005464_abnormal_platelet_physiology | 1.92806068 |
| 24 | MP0009053_abnormal_anal_canal | 1.91371649 |
| 25 | MP0006292_abnormal_olfactory_placode | 1.87694408 |
| 26 | MP0003123_paternal_imprinting | 1.86500377 |
| 27 | MP0003890_abnormal_embryonic-extraembry | 1.82469810 |
| 28 | MP0005332_abnormal_amino_acid | 1.81242691 |
| 29 | MP0002160_abnormal_reproductive_system | 1.77130697 |
| 30 | MP0003879_abnormal_hair_cell | 1.56758666 |
| 31 | MP0005379_endocrine/exocrine_gland_phen | 1.53595221 |
| 32 | MP0008961_abnormal_basal_metabolism | 1.52117172 |
| 33 | MP0002118_abnormal_lipid_homeostasis | 1.47884651 |
| 34 | MP0008872_abnormal_physiological_respon | 1.40489271 |
| 35 | MP0005084_abnormal_gallbladder_morpholo | 1.38315722 |
| 36 | MP0002837_dystrophic_cardiac_calcinosis | 1.33371804 |
| 37 | MP0005409_darkened_coat_color | 1.33343012 |
| 38 | MP0005389_reproductive_system_phenotype | 1.32545707 |
| 39 | MP0003011_delayed_dark_adaptation | 1.31944429 |
| 40 | MP0005670_abnormal_white_adipose | 1.30687442 |
| 41 | MP0000537_abnormal_urethra_morphology | 1.28702939 |
| 42 | MP0003724_increased_susceptibility_to | 1.23551369 |
| 43 | MP0004130_abnormal_muscle_cell | 1.23049298 |
| 44 | MP0002089_abnormal_postnatal_growth/wei | 1.22143066 |
| 45 | MP0004145_abnormal_muscle_electrophysio | 1.21190715 |
| 46 | MP0000609_abnormal_liver_physiology | 1.20358587 |
| 47 | MP0003646_muscle_fatigue | 1.17222402 |
| 48 | MP0001348_abnormal_lacrimal_gland | 1.13360029 |
| 49 | MP0003638_abnormal_response/metabolism_ | 1.10568202 |
| 50 | MP0003436_decreased_susceptibility_to | 1.05374071 |
| 51 | MP0005636_abnormal_mineral_homeostasis | 1.05307898 |
| 52 | MP0001986_abnormal_taste_sensitivity | 1.02073806 |
| 53 | MP0003942_abnormal_urinary_system | 0.99506370 |
| 54 | MP0000685_abnormal_immune_system | 0.96716254 |
| 55 | MP0002132_abnormal_respiratory_system | 0.96670436 |
| 56 | MP0004883_abnormal_blood_vessel | 0.96090360 |
| 57 | MP0001485_abnormal_pinna_reflex | 0.94211650 |
| 58 | MP0001919_abnormal_reproductive_system | 0.90498323 |
| 59 | MP0005164_abnormal_response_to | 0.90408574 |
| 60 | MP0009642_abnormal_blood_homeostasis | 0.88879228 |
| 61 | MP0005551_abnormal_eye_electrophysiolog | 0.88576575 |
| 62 | MP0003121_genomic_imprinting | 0.88493242 |
| 63 | MP0009765_abnormal_xenobiotic_induced | 0.87321735 |
| 64 | MP0008004_abnormal_stomach_pH | 0.84258511 |
| 65 | MP0005319_abnormal_enzyme/_coenzyme | 0.80257936 |
| 66 | MP0009643_abnormal_urine_homeostasis | 0.78558781 |
| 67 | MP0003632_abnormal_nervous_system | 0.76705676 |
| 68 | MP0003878_abnormal_ear_physiology | 0.75674653 |
| 69 | MP0005377_hearing/vestibular/ear_phenot | 0.75674653 |
| 70 | MP0001764_abnormal_homeostasis | 0.75477158 |
| 71 | MP0000639_abnormal_adrenal_gland | 0.74941477 |
| 72 | MP0000598_abnormal_liver_morphology | 0.74258053 |
| 73 | MP0003315_abnormal_perineum_morphology | 0.74226787 |
| 74 | MP0005220_abnormal_exocrine_pancreas | 0.72732691 |
| 75 | MP0005410_abnormal_fertilization | 0.68401481 |
| 76 | MP0003119_abnormal_digestive_system | 0.66884173 |
| 77 | MP0008789_abnormal_olfactory_epithelium | 0.66846875 |
| 78 | MP0005376_homeostasis/metabolism_phenot | 0.66516869 |
| 79 | MP0003172_abnormal_lysosome_physiology | 0.65915494 |
| 80 | MP0005448_abnormal_energy_balance | 0.65630515 |
| 81 | MP0009115_abnormal_fat_cell | 0.65623636 |
| 82 | MP0002282_abnormal_trachea_morphology | 0.64386670 |
| 83 | MP0002249_abnormal_larynx_morphology | 0.63823521 |
| 84 | MP0004133_heterotaxia | 0.62127786 |
| 85 | MP0001188_hyperpigmentation | 0.61940554 |
| 86 | MP0004264_abnormal_extraembryonic_tissu | 0.61257224 |
| 87 | MP0002928_abnormal_bile_duct | 0.60732892 |
| 88 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.59975346 |
| 89 | MP0005195_abnormal_posterior_eye | 0.59502793 |
| 90 | MP0008469_abnormal_protein_level | 0.59240743 |
| 91 | MP0005187_abnormal_penis_morphology | 0.57404748 |
| 92 | MP0003953_abnormal_hormone_level | 0.56258922 |
| 93 | MP0002135_abnormal_kidney_morphology | 0.55251302 |
| 94 | MP0002557_abnormal_social/conspecific_i | 0.54378029 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.53151081 |
| 96 | MP0001661_extended_life_span | 0.52304726 |
| 97 | MP0001293_anophthalmia | 0.51876472 |
| 98 | MP0005499_abnormal_olfactory_system | 0.49572766 |
| 99 | MP0005394_taste/olfaction_phenotype | 0.49572766 |
| 100 | MP0001440_abnormal_grooming_behavior | 0.48913792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Spontaneous abortion (HP:0005268) | 6.74241814 |
| 2 | Deep venous thrombosis (HP:0002625) | 6.66938316 |
| 3 | Hypobetalipoproteinemia (HP:0003563) | 6.42577019 |
| 4 | Abnormality of the common coagulation pathway (HP:0010990) | 5.94224803 |
| 5 | Prolonged partial thromboplastin time (HP:0003645) | 5.45874458 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 5.04146418 |
| 7 | Hypolipoproteinemia (HP:0010981) | 4.87575904 |
| 8 | Complement deficiency (HP:0004431) | 4.76167211 |
| 9 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.67581928 |
| 10 | Osteomalacia (HP:0002749) | 4.40463986 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.36654622 |
| 12 | Joint hemorrhage (HP:0005261) | 4.34245351 |
| 13 | Gingival bleeding (HP:0000225) | 4.29218775 |
| 14 | Xanthomatosis (HP:0000991) | 4.22495979 |
| 15 | Hypoalphalipoproteinemia (HP:0003233) | 3.94054037 |
| 16 | Glomerulonephritis (HP:0000099) | 3.78732678 |
| 17 | Hyperglycinemia (HP:0002154) | 3.73668360 |
| 18 | Intrahepatic cholestasis (HP:0001406) | 3.73387101 |
| 19 | Abnormality of complement system (HP:0005339) | 3.53957255 |
| 20 | Abnormality of the nasal septum (HP:0000419) | 3.35676155 |
| 21 | Epidermoid cyst (HP:0200040) | 3.32027586 |
| 22 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.26247684 |
| 23 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.26056812 |
| 24 | Fused cervical vertebrae (HP:0002949) | 3.16301824 |
| 25 | Conjugated hyperbilirubinemia (HP:0002908) | 2.96626816 |
| 26 | Retinal atrophy (HP:0001105) | 2.89422305 |
| 27 | Hypercholesterolemia (HP:0003124) | 2.88711399 |
| 28 | Fat malabsorption (HP:0002630) | 2.86334580 |
| 29 | Amyloidosis (HP:0011034) | 2.80151919 |
| 30 | Menorrhagia (HP:0000132) | 2.78274598 |
| 31 | Acanthocytosis (HP:0001927) | 2.77341010 |
| 32 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.74518981 |
| 33 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.61717023 |
| 34 | Decreased subcutaneous fat (HP:0001002) | 2.58290742 |
| 35 | Hypoplasia of the fovea (HP:0007750) | 2.51653755 |
| 36 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.51653755 |
| 37 | Bilateral microphthalmos (HP:0007633) | 2.48610773 |
| 38 | Systemic lupus erythematosus (HP:0002725) | 2.47927770 |
| 39 | Enlarged kidneys (HP:0000105) | 2.46585027 |
| 40 | Fatigable weakness (HP:0003473) | 2.44000559 |
| 41 | Abnormality of the neuromuscular junction (HP:0003398) | 2.44000559 |
| 42 | Hypoplasia of the uterus (HP:0000013) | 2.40101223 |
| 43 | Pigmentary retinal degeneration (HP:0001146) | 2.37594727 |
| 44 | Thrombophlebitis (HP:0004418) | 2.31786889 |
| 45 | Alveolar cell carcinoma (HP:0006519) | 2.31714945 |
| 46 | Joint swelling (HP:0001386) | 2.27962382 |
| 47 | Short hallux (HP:0010109) | 2.26365817 |
| 48 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.23965011 |
| 49 | Nephritis (HP:0000123) | 2.21808626 |
| 50 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.21277351 |
| 51 | Epistaxis (HP:0000421) | 2.19851587 |
| 52 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.19460522 |
| 53 | Vitreoretinal degeneration (HP:0000655) | 2.19024186 |
| 54 | Abnormality of urine glucose concentration (HP:0011016) | 2.15035407 |
| 55 | Glycosuria (HP:0003076) | 2.15035407 |
| 56 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.14941369 |
| 57 | Abnormality of glycine metabolism (HP:0010895) | 2.13484029 |
| 58 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.13484029 |
| 59 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.04687793 |
| 60 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.04512445 |
| 61 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.04338746 |
| 62 | Chronic hepatic failure (HP:0100626) | 2.01117855 |
| 63 | Genetic anticipation (HP:0003743) | 2.00013014 |
| 64 | Abnormality of subcutaneous fat tissue (HP:0001001) | 1.99640078 |
| 65 | Morphological abnormality of the middle ear (HP:0008609) | 1.99266827 |
| 66 | Poikilocytosis (HP:0004447) | 1.97981582 |
| 67 | Short 1st metacarpal (HP:0010034) | 1.97753551 |
| 68 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.97753551 |
| 69 | Symphalangism affecting the phalanges of the hand (HP:0009773) | 1.97538823 |
| 70 | Cerebral palsy (HP:0100021) | 1.94760121 |
| 71 | Hyperammonemia (HP:0001987) | 1.89715759 |
| 72 | Abnormality of vitamin metabolism (HP:0100508) | 1.89680905 |
| 73 | Vascular calcification (HP:0004934) | 1.86604616 |
| 74 | Abnormality of serum amino acid levels (HP:0003112) | 1.85984597 |
| 75 | Prolonged bleeding time (HP:0003010) | 1.85795815 |
| 76 | Skin nodule (HP:0200036) | 1.83600731 |
| 77 | Abnormality of the 1st metacarpal (HP:0010009) | 1.83375552 |
| 78 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.81269741 |
| 79 | Abnormal biliary tract physiology (HP:0012439) | 1.80987439 |
| 80 | Bile duct proliferation (HP:0001408) | 1.80987439 |
| 81 | Pendular nystagmus (HP:0012043) | 1.80569734 |
| 82 | Congenital stationary night blindness (HP:0007642) | 1.80488157 |
| 83 | Synostosis of carpal bones (HP:0005048) | 1.80081209 |
| 84 | Purpura (HP:0000979) | 1.79482992 |
| 85 | Stenosis of the external auditory canal (HP:0000402) | 1.79162671 |
| 86 | Facial shape deformation (HP:0011334) | 1.77401389 |
| 87 | Potter facies (HP:0002009) | 1.77401389 |
| 88 | Stomach cancer (HP:0012126) | 1.76485503 |
| 89 | Aplasia/Hypoplasia of the macula (HP:0008059) | 1.76161446 |
| 90 | Goiter (HP:0000853) | 1.75254597 |
| 91 | Abnormality of the fovea (HP:0000493) | 1.74225273 |
| 92 | Easy fatigability (HP:0003388) | 1.73629265 |
| 93 | Abnormal delivery (HP:0001787) | 1.73215036 |
| 94 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 1.73109937 |
| 95 | Renal cortical cysts (HP:0000803) | 1.71394038 |
| 96 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.70415091 |
| 97 | Short femoral neck (HP:0100864) | 1.70088025 |
| 98 | Diastasis recti (HP:0001540) | 1.68434712 |
| 99 | Synostosis involving the elbow (HP:0003938) | 1.68020169 |
| 100 | Humeroradial synostosis (HP:0003041) | 1.68020169 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PIK3CG | 3.04870614 |
| 2 | FLT3 | 2.90630310 |
| 3 | GRK1 | 2.88226646 |
| 4 | MAPKAPK3 | 2.71802462 |
| 5 | PKN2 | 2.70835039 |
| 6 | TNK2 | 2.50270747 |
| 7 | FRK | 2.47843984 |
| 8 | AKT3 | 2.29448388 |
| 9 | WNK4 | 2.19593928 |
| 10 | PDK2 | 2.10211002 |
| 11 | KIT | 1.90724990 |
| 12 | PLK2 | 1.86668302 |
| 13 | WNK3 | 1.76080293 |
| 14 | NTRK3 | 1.69368423 |
| 15 | STK16 | 1.65657908 |
| 16 | DYRK1B | 1.62314118 |
| 17 | TEC | 1.56194437 |
| 18 | FES | 1.55653351 |
| 19 | PIK3CA | 1.47622594 |
| 20 | ERBB2 | 1.43612055 |
| 21 | BTK | 1.42199769 |
| 22 | WNK1 | 1.41967068 |
| 23 | MUSK | 1.38749376 |
| 24 | PINK1 | 1.33706703 |
| 25 | GRK6 | 1.32563400 |
| 26 | PRKAA1 | 1.28525542 |
| 27 | MAP2K2 | 1.26936695 |
| 28 | SGK223 | 1.25966745 |
| 29 | SGK494 | 1.25966745 |
| 30 | FGFR3 | 1.25915821 |
| 31 | CSK | 1.20741480 |
| 32 | ACVR1B | 1.16323189 |
| 33 | PDPK1 | 1.14827191 |
| 34 | SGK2 | 1.14358202 |
| 35 | PRKACG | 1.12311575 |
| 36 | MAP2K3 | 1.11077378 |
| 37 | FGFR4 | 1.06982724 |
| 38 | PDK1 | 1.06802364 |
| 39 | LYN | 1.05772187 |
| 40 | MAP3K9 | 1.00543005 |
| 41 | INSRR | 0.95676721 |
| 42 | MARK2 | 0.94239288 |
| 43 | EEF2K | 0.93177186 |
| 44 | HCK | 0.92071830 |
| 45 | RPS6KB1 | 0.89891253 |
| 46 | SGK3 | 0.88984999 |
| 47 | ABL2 | 0.88750085 |
| 48 | RPS6KA6 | 0.88313354 |
| 49 | ITK | 0.86809706 |
| 50 | PAK3 | 0.86309545 |
| 51 | MAP3K2 | 0.86247735 |
| 52 | MATK | 0.85755810 |
| 53 | MAPK15 | 0.85447566 |
| 54 | IKBKB | 0.85024610 |
| 55 | CAMK1G | 0.84244608 |
| 56 | RPS6KA2 | 0.84238099 |
| 57 | PRKCG | 0.83775044 |
| 58 | PRKCQ | 0.81823945 |
| 59 | PRKAA2 | 0.77908466 |
| 60 | RET | 0.77894130 |
| 61 | SGK1 | 0.77676213 |
| 62 | TAOK3 | 0.76241676 |
| 63 | CSF1R | 0.72847763 |
| 64 | EPHB1 | 0.69487059 |
| 65 | SYK | 0.67449274 |
| 66 | LCK | 0.67122471 |
| 67 | PRKCZ | 0.66750776 |
| 68 | CAMK1D | 0.65611049 |
| 69 | RPS6KC1 | 0.63174185 |
| 70 | RPS6KL1 | 0.63174185 |
| 71 | MAPK11 | 0.63043363 |
| 72 | INSR | 0.62928242 |
| 73 | PRKACA | 0.62729962 |
| 74 | FYN | 0.62185362 |
| 75 | FGFR2 | 0.62026956 |
| 76 | TYK2 | 0.61006502 |
| 77 | TXK | 0.59662502 |
| 78 | BMPR1B | 0.56643132 |
| 79 | MAP3K11 | 0.56405783 |
| 80 | STK39 | 0.55976192 |
| 81 | SIK2 | 0.55488405 |
| 82 | MAP2K4 | 0.53794454 |
| 83 | JAK2 | 0.50263783 |
| 84 | MAP2K6 | 0.49626094 |
| 85 | ZAP70 | 0.49123837 |
| 86 | PRKCB | 0.48359888 |
| 87 | MAPK9 | 0.48250162 |
| 88 | MAPK3 | 0.48247514 |
| 89 | TYRO3 | 0.47986223 |
| 90 | BMX | 0.46917996 |
| 91 | MAPK13 | 0.46285610 |
| 92 | RPS6KA3 | 0.45124307 |
| 93 | STK11 | 0.44130908 |
| 94 | IGF1R | 0.43497250 |
| 95 | GRK5 | 0.43207600 |
| 96 | PRKCA | 0.42746818 |
| 97 | PRKG1 | 0.42185007 |
| 98 | CSNK1E | 0.41621274 |
| 99 | CDK9 | 0.40775384 |
| 100 | MAPK8 | 0.40686295 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.18649507 |
| 2 | * Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 4.04734373 |
| 3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.97261820 |
| 4 | * Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.48831227 |
| 5 | * Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.00644903 |
| 6 | * Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.93100613 |
| 7 | * Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.86548305 |
| 8 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.76355940 |
| 9 | * Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.68238304 |
| 10 | * Retinol metabolism_Homo sapiens_hsa00830 | 2.67993220 |
| 11 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.45900013 |
| 12 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.27708360 |
| 13 | * Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.24710899 |
| 14 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.14797861 |
| 15 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 2.04688248 |
| 16 | * Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.03701385 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.97833960 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.95655401 |
| 19 | * Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.89450076 |
| 20 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.81672148 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.81383978 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71092473 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.66027398 |
| 24 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.62004185 |
| 25 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.57844554 |
| 26 | Peroxisome_Homo sapiens_hsa04146 | 1.53991377 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.48532242 |
| 28 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.46099255 |
| 29 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.45771362 |
| 30 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.45544968 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.36570632 |
| 32 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.35704705 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.35479741 |
| 34 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.25404832 |
| 35 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.18250454 |
| 36 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.12567425 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.12539463 |
| 38 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05744945 |
| 39 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02712246 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.98887966 |
| 41 | Other glycan degradation_Homo sapiens_hsa00511 | 0.98234310 |
| 42 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.97305046 |
| 43 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.94844828 |
| 44 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.91801464 |
| 45 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90871425 |
| 46 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87675262 |
| 47 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.81922444 |
| 48 | Ribosome_Homo sapiens_hsa03010 | 0.79953636 |
| 49 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.79255474 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 0.77786240 |
| 51 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74696335 |
| 52 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.74319699 |
| 53 | Insulin resistance_Homo sapiens_hsa04931 | 0.71644206 |
| 54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.70749060 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.65166972 |
| 56 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.64497232 |
| 57 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59455408 |
| 58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.59035928 |
| 59 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54941344 |
| 60 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.53306997 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51596247 |
| 62 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48659352 |
| 63 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.47887986 |
| 64 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46846206 |
| 65 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.46333205 |
| 66 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.45717027 |
| 67 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43185245 |
| 68 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.40333379 |
| 69 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.38104835 |
| 70 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.34646641 |
| 71 | Prion diseases_Homo sapiens_hsa05020 | 0.31904280 |
| 72 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.30635263 |
| 73 | Phototransduction_Homo sapiens_hsa04744 | 0.29850229 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.25831676 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25634215 |
| 76 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.25347799 |
| 77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.24244655 |
| 78 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22371812 |
| 79 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21198797 |
| 80 | Mineral absorption_Homo sapiens_hsa04978 | 0.19757161 |
| 81 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18184798 |
| 82 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.15811015 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.15691489 |
| 84 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.15132573 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.12021990 |
| 86 | Renin secretion_Homo sapiens_hsa04924 | 0.11531934 |
| 87 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.10224840 |
| 88 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.09837915 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.09003811 |
| 90 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.08121569 |
| 91 | Lysine degradation_Homo sapiens_hsa00310 | 0.07379050 |
| 92 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.07047918 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.06021146 |
| 94 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.05357585 |
| 95 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.05250403 |
| 96 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.04758276 |
| 97 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.04524741 |
| 98 | Insulin secretion_Homo sapiens_hsa04911 | 0.03837635 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.03531285 |
| 100 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.02628862 |

